增塑剂对聚合物维持药物过饱和的影响

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Maryam Maghsoodi, Ahmadreza Shahidi, Ali Nokhodchi
{"title":"增塑剂对聚合物维持药物过饱和的影响","authors":"Maryam Maghsoodi,&nbsp;Ahmadreza Shahidi,&nbsp;Ali Nokhodchi","doi":"10.1007/s12247-025-10014-7","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>One of the widely used methods to inhibit precipitation and provide supersaturation stabilization of poorly water-soluble drugs in aqueous solution is the use of polymers. To enhance the precipitation inhibitory effect of a polymer, its fast dissolution is a prerequisite, while many polymers have extended-release profiles. The present study investigates the impact of four plasticizers, including glycerol (GLY), polyethylene glycol 400 (PEG), methylparaben (MP) and propylparaben (PP), on the supersaturation stabilization of cinnarizine (CNZ) as a poorly water-soluble drug using eudragit S100 (Eu) as a polymeric precipitation inhibitor.</p><h3>Methods</h3><p>The supersaturation behavior of CNZ in the presence of Eu, plasticizers, plasticizer/Eu physical mixtures, and plasticized Eu was evaluated and compared to identify the effect of plasticizers on the Eu-mediated supersaturation stabilization of CNZ.</p><h3>Results</h3><p>For MP, PP and PEG, when the plasticizers were physically blended with Eu, no significant improvement in CNZ supersaturation was found compared to Eu alone. However, plasticized Eu with each of these plasticizers resulted in much higher supersaturation stabilization of CNZ compared to polymer alone, which might be due to the higher dissolution rate of polymer with plasticizer. Contrarily, GLY, irrespective of the mode of addition to Eu, led to lower supersaturation stabilization of CNZ by Eu, which might be due to its interaction with Eu which impedes the preventing effect of Eu on the drug precipitation.</p><h3>Conclusion</h3><p>From these results, incorporating a suitable plasticizer into a polymer can have a strong advantage in further enhancing the drug supersaturation stabilization by the polymer.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"20 4","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Impact of Plasticizer on the Drug Supersaturation Maintenance by Polymer\",\"authors\":\"Maryam Maghsoodi,&nbsp;Ahmadreza Shahidi,&nbsp;Ali Nokhodchi\",\"doi\":\"10.1007/s12247-025-10014-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>One of the widely used methods to inhibit precipitation and provide supersaturation stabilization of poorly water-soluble drugs in aqueous solution is the use of polymers. To enhance the precipitation inhibitory effect of a polymer, its fast dissolution is a prerequisite, while many polymers have extended-release profiles. The present study investigates the impact of four plasticizers, including glycerol (GLY), polyethylene glycol 400 (PEG), methylparaben (MP) and propylparaben (PP), on the supersaturation stabilization of cinnarizine (CNZ) as a poorly water-soluble drug using eudragit S100 (Eu) as a polymeric precipitation inhibitor.</p><h3>Methods</h3><p>The supersaturation behavior of CNZ in the presence of Eu, plasticizers, plasticizer/Eu physical mixtures, and plasticized Eu was evaluated and compared to identify the effect of plasticizers on the Eu-mediated supersaturation stabilization of CNZ.</p><h3>Results</h3><p>For MP, PP and PEG, when the plasticizers were physically blended with Eu, no significant improvement in CNZ supersaturation was found compared to Eu alone. However, plasticized Eu with each of these plasticizers resulted in much higher supersaturation stabilization of CNZ compared to polymer alone, which might be due to the higher dissolution rate of polymer with plasticizer. Contrarily, GLY, irrespective of the mode of addition to Eu, led to lower supersaturation stabilization of CNZ by Eu, which might be due to its interaction with Eu which impedes the preventing effect of Eu on the drug precipitation.</p><h3>Conclusion</h3><p>From these results, incorporating a suitable plasticizer into a polymer can have a strong advantage in further enhancing the drug supersaturation stabilization by the polymer.</p></div>\",\"PeriodicalId\":656,\"journal\":{\"name\":\"Journal of Pharmaceutical Innovation\",\"volume\":\"20 4\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Innovation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s12247-025-10014-7\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-025-10014-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

目的高分子聚合物是目前广泛应用的抑制难水溶性药物在水溶液中沉淀和提供过饱和稳定性的方法之一。为了提高聚合物的抑沉淀效果,其快速溶解是先决条件,而许多聚合物具有缓释特性。本研究研究了四种增塑剂,包括甘油(GLY),聚乙二醇400 (PEG),对羟基苯甲酸甲酯(MP)和对羟基苯甲酸丙酯(PP),对肉桂嗪(CNZ)过饱和稳定性的影响。肉桂嗪是一种水溶性差的药物,以乌拉吉特S100 (Eu)为聚合物沉淀抑制剂。方法研究了Eu、增塑剂、增塑剂/Eu物理混合物和增塑剂Eu存在时CNZ的过饱和行为,并比较了增塑剂对Eu介导的CNZ过饱和稳定性的影响。结果对于MP, PP和PEG,当增塑剂与Eu物理混合时,与单独使用Eu相比,CNZ过饱和没有明显改善。然而,与单独使用聚合物相比,使用这些增塑剂对Eu进行增塑后,CNZ的过饱和稳定性要高得多,这可能是由于聚合物与增塑剂的溶解速度更快。与此相反,无论加入Eu的方式如何,GLY均导致Eu对CNZ的过饱和稳定性较低,这可能是由于GLY与Eu的相互作用阻碍了Eu对药物沉淀的预防作用。结论在聚合物中掺入合适的增塑剂有利于进一步增强聚合物对药物的过饱和稳定性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The Impact of Plasticizer on the Drug Supersaturation Maintenance by Polymer

The Impact of Plasticizer on the Drug Supersaturation Maintenance by Polymer

Objective

One of the widely used methods to inhibit precipitation and provide supersaturation stabilization of poorly water-soluble drugs in aqueous solution is the use of polymers. To enhance the precipitation inhibitory effect of a polymer, its fast dissolution is a prerequisite, while many polymers have extended-release profiles. The present study investigates the impact of four plasticizers, including glycerol (GLY), polyethylene glycol 400 (PEG), methylparaben (MP) and propylparaben (PP), on the supersaturation stabilization of cinnarizine (CNZ) as a poorly water-soluble drug using eudragit S100 (Eu) as a polymeric precipitation inhibitor.

Methods

The supersaturation behavior of CNZ in the presence of Eu, plasticizers, plasticizer/Eu physical mixtures, and plasticized Eu was evaluated and compared to identify the effect of plasticizers on the Eu-mediated supersaturation stabilization of CNZ.

Results

For MP, PP and PEG, when the plasticizers were physically blended with Eu, no significant improvement in CNZ supersaturation was found compared to Eu alone. However, plasticized Eu with each of these plasticizers resulted in much higher supersaturation stabilization of CNZ compared to polymer alone, which might be due to the higher dissolution rate of polymer with plasticizer. Contrarily, GLY, irrespective of the mode of addition to Eu, led to lower supersaturation stabilization of CNZ by Eu, which might be due to its interaction with Eu which impedes the preventing effect of Eu on the drug precipitation.

Conclusion

From these results, incorporating a suitable plasticizer into a polymer can have a strong advantage in further enhancing the drug supersaturation stabilization by the polymer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Pharmaceutical Innovation
Journal of Pharmaceutical Innovation PHARMACOLOGY & PHARMACY-
CiteScore
3.70
自引率
3.80%
发文量
90
审稿时长
>12 weeks
期刊介绍: The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories: Materials science, Product design, Process design, optimization, automation and control, Facilities; Information management, Regulatory policy and strategy, Supply chain developments , Education and professional development, Journal of Pharmaceutical Innovation publishes four issues a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信